J Am Coll Cardiol December 2018 PMID 30261237

Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation: The ULTIMATE Trial.

Junjie Zhang, Xiaofei Gao, Jing Kan, Zhen Ge, Leng Han, Shu Lu, Nailiang Tian, Song Lin, Qinghua Lu, Xueming Wu, Qihua Li, Zhizhong Liu, Yan Chen, Xuesong Qian, Juan Wang

Full text PDF Download social card

Mentions

Peak: 2 in Dec 2018

across 5 sources since Dec 2018

Extended reach

113,574

potential audience

Total likes

Video views

387

Mentions per month

Dec 2018 – Oct 2024

Where it's discussed

X / Twitter7 posts
News6 articles
Facebook4 posts
YouTube3 videos
Blogs2 articles

AI synopsis

What people are saying

Overall, the discussions support the trial's findings that IVUS guidance improves outcomes, with comments like 'aporta datos para disminuir la falla del vaso tratado' and recognition of the study's large sample size. Users engage by analyzing the implications, such as the limited representation of certain patient groups, indicating a balanced and meaningful conversation about the article's significance.

AgreementModerate agreement

Most discussions express support or acknowledge the positive findings of the ULTIMATE trial, indicating a general agreement on its significance.

InterestModerate interest

Participants demonstrate moderate interest, referencing specific data points and limitations, but overall engagement remains measured.

EngagementModerate engagement

Several posts reference the methodology, sample size, and limitations, showing thoughtful analysis and deeper discussion.

ImpactModerate impact

The remarks suggest the trial could influence clinical practice, with some highlighting the potential for improved patient outcomes.

Abstract in brief

The study found that using intravascular ultrasound (IVUS) to guide drug-eluting stent (DES) placement results in fewer major adverse heart-related events within 12 months compared to traditional angiography guidance.
Patients who achieved optimal results based on IVUS criteria experienced even better outcomes, including lower rates of target-vessel failure and stent-related complications.
Overall, IVUS guidance improves clinical outcomes in a broad group of patients undergoing DES implantation, highlighting the importance of using IVUS for optimal procedure success.]

Read the full abstract

All mentions

Transcatheter Mitral Valve Repair and Cardiology Updates

The CafÃ© com Journal delivers updates on recent cardiology publications each week. This session discusses innovative studies, including the impact of transcatheter mitral valve repair in heart failure patients…

CardioLearning · Dec 18, 2018 356 views

IVUS Guidance Enhances Outcomes in Drug-Eluting Stent Implantation

Intravascular ultrasound (IVUS) guidance for drug-eluting stent placement leads to fewer major adverse cardiac events within 12 months compared to angiography.

Few Group · Dec 31, 2018 17 views

IVUS Guidance Improves Outcomes in Drug-Eluting Stent Procedures

This video discusses the ULTIMATE trial, showing that intravascular ultrasound guidance during drug-eluting stent placement leads to fewer adverse heart events compared to angiography guidance, emphasizing the…

Medscape · Mar 27, 2024 15 views

Juan Senior

@jsenior64 · X

Para guiar el éxito de la intervención este estudio es bastante interesante, aporta datos para disminuir la falla del vaso tratado. ULTÍMATE Trial. https://t.co/b9F9b4bvLo

Oct 10, 2024 · 11,059 followers View post →

Mamas A. Mamas

@mmamas1973 · X

RT @agtruesdell: @aspergian1 @mmamas1973 @jedicath @rotamonster @ShariqShamimMD @perc_surgeon @ziadalinyc

Mar 7, 2023 · 2 shares · 79,773 followers View post →

Alex Truesdell

@agtruesdell · X

@aspergian1 @mmamas1973 @jedicath @rotamonster @ShariqShamimMD @perc_surgeon @ziadalinyc

Mar 7, 2023 · 18 likes · 2 shares · 13,497 followers View post →

Allison Dupont, MD

@Allison_Dupont · X

@XavierPrida @cardioPCImom https://t.co/v7EVuLX0fN

Nov 4, 2021 · 1 like · 4,083 followers View post →

Charles Pollack MD

@md_pollack · X

RT @cardiomet_CE: 21) However, only 12% of the enrolled pts presented with STEMI or NSTE-ACS, limiting its validity in NSTE-ACS settings. h…

Aug 4, 2021 · 1 share · 281 followers View post →

cardio-met

@cardiomet_CE · X

21) However, only 12% of the enrolled pts presented with STEMI or NSTE-ACS, limiting its validity in NSTE-ACS settings. https://t.co/wsKLbreX25 https://t.co/UgbGlZDwYp

Aug 4, 2021 · 4 likes · 1 share · 4,158 followers View post →

Grigoris Karamasis

@grkaramasis · X

Jun 18, 2020 · 2 likes · 325 followers View post →